BioVie Inc. Assets, Noncurrent
BioVie Inc. (BIVI) had Assets, Noncurrent of $1.20 million as of 2022-12-31, per its 10-Q filed 2023-02-10.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:AssetsNoncurrent · last filed 2023-02-10
- 2022-12-31: Assets, Noncurrent $1.20M.
- 2022-09-30: Assets, Noncurrent $1.27M.
- 2022-06-30: Assets, Noncurrent $1.33M.
- 2022-03-31: Assets, Noncurrent $1.40M.
| Period end | Assets, Noncurrent |
|---|---|
| 2022-12-31 | $1.20M 10-Q · filed 2023-02-10 |
| 2022-09-30 | $1.27M 10-Q · filed 2022-11-04 |
| 2022-06-30 | $1.33M 10-Q · filed 2023-02-10 |
| 2022-03-31 | $1.40M 10-Q · filed 2022-05-11 |
| 2021-12-31 | $1.33M 10-Q · filed 2022-02-08 |
| 2021-09-30 | $1.38M 10-Q · filed 2021-11-10 |
| 2021-06-30 | $1.44M 10-K · filed 2022-09-27 |
| 2021-03-31 | $1.50M 10-Q · filed 2021-05-10 |
| 2020-12-31 | $1.56M 10-Q · filed 2021-01-29 |
| 2020-09-30 | $1.61M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $1.67M 10-K · filed 2021-08-30 |
| 2020-03-31 | $1.73M 10-Q · filed 2020-05-13 |
| 2019-12-31 | $1.79M 10-Q · filed 2020-02-13 |
| 2019-09-30 | $1.84M 10-Q · filed 2019-11-19 |
| 2019-06-30 | $1.90M 10-K/A · filed 2020-08-07 |
| 2019-05-10 | $1.96M 10-Q · filed 2019-05-10 |
| 2018-12-31 | $2.02M 10-Q · filed 2019-02-12 |
| 2018-09-30 | $2.07M 10-Q · filed 2018-11-14 |
| 2018-06-30 | $2.13M 10-K · filed 2019-09-27 |
| 2018-03-31 | $2.19M 10-Q · filed 2018-05-14 |
| 2017-12-31 | $2.24M 10-Q · filed 2018-02-14 |
| 2017-09-30 | $2.30M 10-Q · filed 2017-11-08 |
| 2017-06-30 | $2.36M 10-K · filed 2018-10-05 |
| 2017-03-31 | $2.42M 10-Q · filed 2017-05-09 |
| 2016-12-31 | $2.47M 10-Q · filed 2017-02-07 |
| 2016-09-30 | $2.53M 10-Q/A · filed 2017-01-19 |
| 2016-06-30 | $2.59M 10-K · filed 2017-08-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |